Conexeu Sciences (CNXU) vs PolyPid (PYPD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Conexeu Sciences is the larger company by market cap ($109.7 million vs $103.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNXU | PYPD |
|---|---|---|
| Share price | $3.89 | $5.07 |
| Market cap | $109.72M | $102.98M |
| 1-day change | +12.75% | +3.47% |
| YTD return | — | +16.82% |
| 1-year return | — | +52.48% |
| 5-year return | — | -97.75% |
| EPS (TTM) | $-0.69 | $-1.48 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $18.79 | $5.73 |
| 52-week low | $3.05 | $3.10 |
| Distance from 52-week high | -79.30% | -11.52% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +414.14% | +131.76% |
| Average volume | 205.86K | 175.46K |
| Shares outstanding | 28.21M | 20.31M |
| Employees | — | 69 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Conexeu Sciences
CNXU stock →Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair.
Health Care · Industrial Specialties
About PolyPid
PYPD stock →PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions.
Health Care · Medical/Dental Instruments · 69 employees
CNXU vs PYPD FAQ
Which is bigger, Conexeu Sciences or PolyPid?
Conexeu Sciences (CNXU) is larger, with a market capitalization of $109.72M compared with $102.98M for PolyPid (PYPD).
Are Conexeu Sciences and PolyPid in the same industry?
Both are in the Health Care sector, but in different industries: Industrial Specialties for Conexeu Sciences and Medical/Dental Instruments for PolyPid.